Elevance Health, Inc. (ELV) · Insider trading
What Elevance Health's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$2.24M
3 insiders, 4 trades
Sold, 12 months
$1.74M
4 insiders, 0% under a plan
Net, 12 months
+$493,095
bought less sold
Latest filing
2026-10-06
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Boudreaux GailDirector, President and CEO | $3.44M | – | 5 | 2026-07-17 | 169,931 |
| Kendrick Charles Morgan JrEVP & President, Commercial | – | $2.30M | 2 | 2026-03-06 | 11,791 |
| Kaye MarkEVP & CFO | – | $1.95M | 1 | 2025-04-24 | 18,977 |
| Penczek Ronald WCAO & Controller | – | $949,861 | 3 | 2026-06-12 | 3,740 |
| Collis Steven HDirector | $869,520 | – | 1 | 2026-03-05 | 3,639 |
| DeVore Susan D.Director | $374,580 | – | 1 | 2025-08-19 | 3,502 |
| Peru Ramiro GDirector | $366,050 | – | 1 | 2026-07-17 | 10,908 |
| Dixon Robert L JrDirector | – | $60,667 | 1 | 2026-06-11 | 10,734 |
| Schulman Amy WDirector | – | $7,475 | 1 | 2026-03-12 | 218 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | Peru Ramiro GDirector | Buy | 1,000 | 366.05 | $366,050 | 10,908 | Form 4 |
| 2026-07-17 | Boudreaux GailDirector, President and CEO | Buy | 680 | 366.41 | $249,159 | 169,931 | Form 4 |
| 2026-07-17 | Boudreaux GailDirector, President and CEO | Buy | 2,045 | 368.25 | $753,071 | 171,976 | Form 4 |
| 2026-06-12 | Penczek Ronald WCAO & Controller | Sale | 369 | 403.16 | $148,766 | 3,740 | Form 4 |
| 2026-06-11 | Dixon Robert L JrDirector | Sale | 151 | 401.77 | $60,667 | 10,734 | Form 4 |
| 2026-05-19 | Penczek Ronald WCAO & Controller | Sale | 1,531 | 403.13 | $617,192 | 4,109 | Form 4 |
| 2026-03-12 | Schulman Amy WDirector | Sale | 26 | 287.50 | $7,475 | 218 | Form 4 |
| 2026-03-06 | Kendrick Charles Morgan JrEVP & President, Commercial | Sale | 3,196 | 284.92 | $910,604 | 11,791 | Form 4 |
| 2026-03-05 | Collis Steven HDirector | Buy | 3,000 | 289.84 | $869,520 | 3,639 | Form 4 |
| 2025-08-19 | DeVore Susan D.Director | Buy | 1,200 | 312.15 | $374,580 | 3,502 | Form 4 |
| 2025-07-18 | Boudreaux GailDirector, President and CEO | Buy | 2,334 | 286.07 | $667,687 | 144,854 | Form 4 |
| 2025-07-18 | Boudreaux GailDirector, President and CEO | Buy | 5,116 | 287.12 | $1.47M | 149,970 | Form 4 |
| 2025-07-18 | Boudreaux GailDirector, President and CEO | Buy | 1,050 | 287.96 | $302,358 | 151,020 | Form 4 |
| 2025-04-24 | Kaye MarkEVP & CFO | Sale | 4,588 | 424.82 | $1.95M | 18,977 | Form 4 |
| 2025-03-10 | Penczek Ronald WCAO & Controller | Sale | 443 | 415.13 | $183,903 | 1,847 | Form 4 |
| 2025-03-05 | Kendrick Charles Morgan JrEVP & President, Commercial | Sale | 3,504 | 396.30 | $1.39M | 10,116 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
54 × grant or award34 × shares withheld for tax2 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-02 | Kaye MarkEVP & CFO | Shares withheld for tax F | −4,161 | 386.43 | 27,876 | Form 4 |
| 2026-10-02 | Kaye MarkEVP & CFO | Grant or award A | +2,627 | – | 30,503 | Form 4 |
| 2026-09-03 | Wessling Erin MEVP & Chief Legal Officer | Shares withheld for tax F | −255 | 414.78 | 7,230 | Form 4 |
| 2026-09-02 | Craig Ryan REVP & Chief HR Officer | Shares withheld for tax F | −144 | 405.84 | 6,530 | Form 4 |
| 2026-09-02 | Wessling Erin MEVP & Chief Legal Officer | Shares withheld for tax F | −94 | 405.84 | 7,485 | Form 4 |
| 2026-05-19 | Penczek Ronald WCAO & Controller | Option exercise M | +654 | 271.27 | 4,763 | Form 4 |
| 2026-05-19 | Penczek Ronald WCAO & Controller | Option exercise M | +877 | 311.48 | 5,640 | Form 4 |
| 2026-05-13 | Hay Lewis IIIDirector | Grant or award A | +563 | – | 12,070 | Form 4 |
| 2026-05-13 | Collis Steven HDirector | Grant or award A | +563 | – | 4,202 | Form 4 |
| 2026-05-13 | Peru Ramiro GDirector | Grant or award A | +563 | – | 9,908 | Form 4 |
| 2026-05-13 | Schneider Ryan M.Director | Grant or award A | +563 | – | 7,163 | Form 4 |
| 2026-05-13 | Schulman Amy WDirector | Grant or award A | +563 | – | 781 | Form 4 |
| 2026-05-13 | Dixon Robert L JrDirector | Grant or award A | +563 | – | 10,885 | Form 4 |
| 2026-05-13 | DeVore Susan D.Director | Grant or award A | +563 | – | 4,065 | Form 4 |
| 2026-05-13 | Strable-Soethout Deanna DDirector | Grant or award A | +563 | – | 2,209 | Form 4 |
| 2026-05-13 | Neri Antonio FDirector | Grant or award A | +563 | – | 5,488 | Form 4 |
| 2026-05-13 | Jallal BahijaDirector | Grant or award A | +563 | – | 5,351 | Form 4 |
| 2026-03-03 | Boudreaux GailDirector, President and CEO | Shares withheld for tax F | −1,736 | 284.03 | 169,251 | Form 4 |
| 2026-03-03 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Shares withheld for tax F | −446 | 284.03 | 27,222 | Form 4 |
| 2026-03-03 | Penczek Ronald WCAO & Controller | Shares withheld for tax F | −37 | 284.03 | 4,099 | Form 4 |
| 2026-03-03 | Lavu RatnakarEVP & Chief Digital Info Ofr | Shares withheld for tax F | −222 | 284.03 | 16,149 | Form 4 |
| 2026-03-03 | Norwood Felicia FEVP &Chief Health Benefits Ofr | Shares withheld for tax F | −496 | 284.03 | 38,838 | Form 4 |
| 2026-03-03 | Kaye MarkEVP & CFO | Shares withheld for tax F | −353 | 284.03 | 32,037 | Form 4 |
| 2026-03-03 | Kendrick Charles Morgan JrEVP & President, Commercial | Shares withheld for tax F | −467 | 284.03 | 14,987 | Form 4 |
| 2026-03-03 | Craig Ryan REVP & Chief HR Officer | Shares withheld for tax F | −309 | 284.03 | 6,674 | Form 4 |
| 2026-03-03 | Wessling Erin MEVP & Chief Legal Officer | Shares withheld for tax F | −417 | 284.03 | 7,579 | Form 4 |
| 2026-03-02 | Boudreaux GailDirector, President and CEO | Shares withheld for tax F | −6,713 | 294.07 | 144,307 | Form 4 |
| 2026-03-02 | Boudreaux GailDirector, President and CEO | Grant or award A | +16,153 | – | 160,460 | Form 4 |
| 2026-03-02 | Boudreaux GailDirector, President and CEO | Grant or award A | +10,527 | – | 170,987 | Form 4 |
| 2026-03-02 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Shares withheld for tax F | −1,201 | 294.07 | 24,803 | Form 4 |
| 2026-03-02 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Grant or award A | +2,865 | – | 27,668 | Form 4 |
| 2026-03-02 | Penczek Ronald WCAO & Controller | Shares withheld for tax F | −131 | 294.07 | 1,743 | Form 4 |
| 2026-03-02 | Penczek Ronald WCAO & Controller | Grant or award A | +426 | – | 2,169 | Form 4 |
| 2026-03-02 | Penczek Ronald WCAO & Controller | Grant or award A | +1,701 | – | 3,870 | Form 4 |
| 2026-03-02 | Penczek Ronald WCAO & Controller | Grant or award A | +266 | – | 4,136 | Form 4 |
| 2026-03-02 | Lavu RatnakarEVP & Chief Digital Info Ofr | Shares withheld for tax F | −315 | 294.07 | 4,468 | Form 4 |
| 2026-03-02 | Lavu RatnakarEVP & Chief Digital Info Ofr | Grant or award A | +5,101 | – | 9,569 | Form 4 |
| 2026-03-02 | Lavu RatnakarEVP & Chief Digital Info Ofr | Grant or award A | +6,802 | – | 16,371 | Form 4 |
| 2026-03-02 | Norwood Felicia FEVP &Chief Health Benefits Ofr | Shares withheld for tax F | −1,421 | 294.07 | 30,518 | Form 4 |
| 2026-03-02 | Norwood Felicia FEVP &Chief Health Benefits Ofr | Grant or award A | +5,951 | – | 36,469 | Form 4 |
| 2026-03-02 | Norwood Felicia FEVP &Chief Health Benefits Ofr | Grant or award A | +2,865 | – | 39,334 | Form 4 |
| 2026-03-02 | Kaye MarkEVP & CFO | Shares withheld for tax F | −271 | 294.07 | 15,811 | Form 4 |
| 2026-03-02 | Kaye MarkEVP & CFO | Grant or award A | +6,377 | – | 22,188 | Form 4 |
| 2026-03-02 | Kaye MarkEVP & CFO | Grant or award A | +10,202 | – | 32,390 | Form 4 |
| 2026-03-02 | Kendrick Charles Morgan JrEVP & President, Commercial | Shares withheld for tax F | −1,211 | 294.07 | 8,905 | Form 4 |
| 2026-03-02 | Kendrick Charles Morgan JrEVP & President, Commercial | Grant or award A | +4,017 | – | 12,922 | Form 4 |
| 2026-03-02 | Kendrick Charles Morgan JrEVP & President, Commercial | Grant or award A | +2,532 | – | 15,454 | Form 4 |
| 2026-03-02 | Craig Ryan REVP & Chief HR Officer | Shares withheld for tax F | −25 | 294.07 | 4,007 | Form 4 |
| 2026-03-02 | Craig Ryan REVP & Chief HR Officer | Grant or award A | +2,976 | – | 6,983 | Form 4 |
| 2026-03-02 | Wessling Erin MEVP & Chief Legal Officer | Grant or award A | +2,976 | – | 7,996 | Form 4 |
| 2026-02-02 | Schulman Amy WDirector | Grant or award A | +218 | – | 218 | Form 4 |
| 2026-02-02 | Craig Ryan REVP & Chief HR Officer | Shares withheld for tax F | −279 | 341.83 | 4,032 | Form 4 |
| 2025-10-02 | Kaye MarkEVP & CFO | Shares withheld for tax F | −2,895 | 340.24 | 16,082 | Form 4 |
| 2025-09-03 | Wessling Erin MEVP & Chief Legal Officer | Shares withheld for tax F | −152 | 321.59 | 5,020 | Form 4 |
| 2025-09-02 | Craig Ryan REVP & Chief HR Officer | Grant or award A | +970 | – | 5,353 | Form 4 |
| 2025-09-02 | Wessling Erin MEVP & Chief Legal Officer | Grant or award A | +931 | – | 5,172 | Form 4 |
| 2025-08-01 | Collis Steven HDirector | Grant or award A | +639 | – | 639 | Form 4 |
| 2025-05-14 | Clark R KerryDirector | Grant or award A | +601 | – | 9,640 | Form 4 |
| 2025-05-14 | DeVore Susan D.Director | Grant or award A | +601 | – | 2,302 | Form 4 |
| 2025-05-14 | Dixon Robert L JrDirector | Grant or award A | +601 | – | 10,322 | Form 4 |
| 2025-05-14 | Hay Lewis IIIDirector | Grant or award A | +601 | – | 11,507 | Form 4 |
| 2025-05-14 | Jallal BahijaDirector | Grant or award A | +601 | – | 4,788 | Form 4 |
| 2025-05-14 | Neri Antonio FDirector | Grant or award A | +601 | – | 4,925 | Form 4 |
| 2025-05-14 | Peru Ramiro GDirector | Grant or award A | +601 | – | 9,345 | Form 4 |
| 2025-05-14 | Schneider Ryan M.Director | Grant or award A | +601 | – | 6,600 | Form 4 |
| 2025-05-14 | Strable-Soethout Deanna DDirector | Grant or award A | +601 | – | 1,646 | Form 4 |
| 2025-03-03 | Boudreaux GailDirector, President and CEO | Shares withheld for tax F | −10,396 | 395.50 | 116,313 | Form 4 |
| 2025-03-03 | Boudreaux GailDirector, President and CEO | Grant or award A | +10,620 | – | 126,933 | Form 4 |
| 2025-03-03 | Boudreaux GailDirector, President and CEO | Grant or award A | +15,587 | – | 142,520 | Form 4 |
| 2025-03-03 | Kaye MarkEVP & CFO | Shares withheld for tax F | −270 | 395.50 | 19,961 | Form 4 |
| 2025-03-03 | Kaye MarkEVP & CFO | Grant or award A | +3,604 | – | 23,565 | Form 4 |
| 2025-03-03 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Shares withheld for tax F | −2,281 | 395.50 | 18,756 | Form 4 |
| 2025-03-03 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Grant or award A | +3,035 | – | 21,791 | Form 4 |
| 2025-03-03 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Grant or award A | +4,213 | – | 26,004 | Form 4 |
| 2025-03-03 | Norwood Felicia FEVP & President,Gov Health Ben | Shares withheld for tax F | −2,613 | 395.50 | 24,691 | Form 4 |
| 2025-03-03 | Norwood Felicia FEVP & President,Gov Health Ben | Grant or award A | +3,035 | – | 27,726 | Form 4 |
| 2025-03-03 | Norwood Felicia FEVP & President,Gov Health Ben | Grant or award A | +4,213 | – | 31,939 | Form 4 |
| 2025-03-03 | Lavu RatnakarEVP, Chief Digital & Info Off | Shares withheld for tax F | −312 | 395.50 | 2,444 | Form 4 |
| 2025-03-03 | Lavu RatnakarEVP, Chief Digital & Info Off | Grant or award A | +2,339 | – | 4,783 | Form 4 |
| 2025-03-03 | Penczek Ronald WCAO & Controller | Shares withheld for tax F | −198 | 395.50 | 1,584 | Form 4 |
| 2025-03-03 | Penczek Ronald WCAO & Controller | Grant or award A | +285 | – | 1,869 | Form 4 |
| 2025-03-03 | Penczek Ronald WCAO & Controller | Grant or award A | +421 | – | 2,290 | Form 4 |
| 2025-03-03 | Kendrick Charles Morgan JrEVP & President, Commercial | Shares withheld for tax F | −2,221 | 395.50 | 7,089 | Form 4 |
| 2025-03-03 | Kendrick Charles Morgan JrEVP & President, Commercial | Grant or award A | +2,845 | – | 9,934 | Form 4 |
| 2025-03-03 | Kendrick Charles Morgan JrEVP & President, Commercial | Grant or award A | +3,686 | – | 13,620 | Form 4 |
| 2025-01-03 | Todt Blair WilliamsEVP, CLO & CAO | Shares withheld for tax F | −398 | 371.56 | 15,631 | Form 4 |
| 2024-11-01 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Shares withheld for tax F | −1,649 | 414.01 | 17,238 | Form 4 |
| 2024-11-01 | Haytaian Peter DEVP & Pres Carelon & CarelonRx | Grant or award A | +3,799 | – | 21,037 | Form 4 |
| 2024-11-01 | Kendrick Charles Morgan JrEVP & President, Commercial | Shares withheld for tax F | −846 | 414.01 | 7,577 | Form 4 |
| 2024-11-01 | Kendrick Charles Morgan JrEVP & President, Commercial | Grant or award A | +1,710 | – | 9,287 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.